MedTrace Logo

Potassium Citrate and Crystal Light Lemonade

NCT05389995 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-01-21

No results posted yet for this study

Summary

To define the effect of crystal light, potassium citrate, or both on urinary stone risk factors in patients with a history of stone and hypocitraturia/low pH

Conditions

  • Kidney Stone

Interventions

DRUG

Potassium citrate

7 days potassium citrate followed by 24 hour urine collection

DRUG

Crystal light

7 days crystal light followed by 24 hour urine collection

DRUG

Potassium citrate + crystal light

7 days potassium citrate + crystal light followed by 24 hour urine collection

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2025-04-01
Completion
2027-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05389995 on ClinicalTrials.gov